With MDMA debate spreading beyond biotech, Lykos CEO tries to dispel efficacy, safety concernsWith MDMA debate spreading, Lykos CEO tries to dispel concerns - Fierce Biotech fiercebiotech.com Submitted by fiercebiotech9600 on June 14, 2024 at 6:54 PM in business No comments 32
No hormones, no problem: YourChoice's first-of-its-kind male birth control is safe for men, so far - Fierce Biotech fiercebiotech.com Submitted by fiercebiotech9600 on June 5, 2024 at 4:40 PM in business No comments 24
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccineMerck's 3-pronged cancer strategy stars Moderna-partnered vaccine - Fierce Biotech fiercebiotech.com Submitted by fiercebiotech9600 on June 4, 2024 at 9:11 PM in business No comments 27
ASCO: Jazz shares 'unprecedented' biliary tract cancer data - Fierce Biotech fiercebiotech.com Submitted by fiercebiotech9600 on June 3, 2024 at 8:54 AM in business No comments 26
Evotec makes 'strategic exit' from gene therapy as part of wider shake-upEvotec makes 'strategic exit' from gene therapy as part of wider shake-up - Fierce Biotech fiercebiotech.com Submitted by fiercebiotech9600 on May 24, 2024 at 2:55 AM in business No comments 1
Biogen says hello to HI-Bio, inking $1.15B buyout to expand in immunology - Fierce Biotech fiercebiotech.com Submitted by fiercebiotech9600 on May 23, 2024 at 6:13 PM in business No comments 33
Bayer posts pivotal data on rival to Astellas in menopause space - Fierce Biotech fiercebiotech.com Submitted by fiercebiotech9600 on May 18, 2024 at 10:45 AM in business No comments 59
'We have not seen anything similar': Novo Nordisk pens $600M obesity pact with Flagship's Metaphore'We have not seen anything similar': Novo Nordisk pens $600M obesity pact with Flagship's Metaphore - Fierce Biotech fiercebiotech.com Submitted by fiercebiotech9600 on May 10, 2024 at 11:00 AM in business No comments 1
FDA advisers to weigh first psychedelic therapy in early JuneFDA advisers to weigh first psychedelic therapy in early June - Fierce Biotech fiercebiotech.com Submitted by fiercebiotech9600 on May 8, 2024 at 3:10 PM in business No comments 6
NanoString files for bankruptcy, explores potential sale amid patent battle with 10x Genomics - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on February 6, 2024 at 3:24 PM in business No comments 45
UPDATE: 2seventy splits once more, sending cell therapy pipeline to Regeneron in dramatic strategic overhaul - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on January 31, 2024 at 4:30 PM in business No comments 49
Week of IPO success stories suggest biotech has reached 'recovery phase' in 2024 - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on January 27, 2024 at 3:21 PM in business No comments 48
Early Lilly data finds gene therapy restored hearing for child - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on January 24, 2024 at 9:59 PM in business No comments 39
Sanofi inks $1.7B Inhibrx buyout, snagging rare disease drug but spinning out cancer programs - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on January 24, 2024 at 10:26 AM in business No comments 48
Editor's Corner: Driverless cars and doorless planes at JPM24 - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on January 13, 2024 at 4:02 PM in business No comments 1
JPM24: Lilly CEO David Ricks to biotechs: 'We're open for business' - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on January 11, 2024 at 12:04 AM in business No comments 7
JPM24, Day 2: GSK, Eli Lilly, Blueprint, SR One and moreJPM24, Day 2: GSK, Eli Lilly, Blueprint, SR One and more - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on January 10, 2024 at 11:15 PM in business No comments 38
JPM24, Day 1: Alphabet biotech's Big Pharma foray; Novartis nabs a Merck KGaA spin-off; J&J, Merck tie up M&A deals - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on January 9, 2024 at 6:00 AM in business No comments 49
Fierce Biotech Layoff Tracker 2024: AlloVir cuts 95% of team; Pfizer R&D site to lay off 285 staffers - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on January 6, 2024 at 4:07 PM in business No comments 1
Cytokinetics' heart failure drug improves exercise capacity, sending shares soaring in long-awaited winCytokinetics' heart failure drug improves exercise capacity, sending shares soaring in long-awaited win - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on December 28, 2023 at 1:43 PM in business No comments 16
First ever drug application for MDMA finally reaches FDA - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on December 14, 2023 at 2:39 PM in business No comments 5
Merck KGaA's BTK drug flunks pivotal multiple sclerosis trials, sending shockwaves through the sector - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on December 7, 2023 at 9:30 AM in business No comments 53
Volatile day for CAR-T biotechs after FDA announces cancer safety review - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on November 29, 2023 at 9:35 PM in business No comments 16
Sickle cell gene therapy process may cause cancer-linked mutations in blood stem cells - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on November 21, 2023 at 2:10 PM in health No comments 54
Scientists reflect on Roche's Alzheimer's failure a year later - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on November 16, 2023 at 10:00 PM in health No comments 12